Terminalia Arjuna

    Written by:
    Peter Woznik

    Fact-checked

    by:

    Giulia Guerrini, Conni Covington
    Last Updated: May 21, 2025

    Arjuna is typically made from the bark of the tree Terminalia arjuna, a large tree common throughout India. It has most often been studied for cardiovascular disease, where it has improved heart failure in some studies. Arjuna has inconsistently improved other cardiac outcomes such as blood pressure.

    Overview

    Dosage information

    Formulation:

    Arjuna has been given as a capsule in many studies,[1][2][3][4][5] though it has been given as a powder as well.[6]

    In the studies reviewed for the writing of this page, there were no measurements of the levels of the constituents in arjuna (such as arjunic acid or others) used in the study interventions.[7]

    Range of dosages studied:

    0.5 grams to 10 grams per day.[5][6]

    Effective dosages:

    Cardiovascular disease

    Adults with cardiovascular disease (e.g., heart failure, metabolic syndrome) or without health conditions: 500 mg 1 to 3 times a day for 1 to 3 months.[3][4][8][9]

    Frequently asked questions

    Update History

    Research Breakdown